Thursday, December 12, 2024
spot_img

South Africa set to participate in two more vaccine trials

Date:

Share post:

spot_img
spot_img

Johannesburg: South Africa is all set to participate in two more COVID-19 vaccine trials by leading pharmaceutical companies starting next month.

Dr Glenda Gray, president and CEO of the South African Medical Research Council, said in an interview with the public interest health website Spotlight on Tuesday that a Johnson & Johnson product called Ad26.COV2-S and a Novavax product called NVX-CoV2373 will be trialled in the country.

The first COVID-19 vaccine trial on the African continent was the Ox1Cov-19 Vaccine VIDA trial, a collaboration with Oxford University, which was started in June in South Africa.

It is led by Professor in Vaccinology at Wits University Shabir Madhi.

Madhi, who is also the lead investigator for the Novavax trial in South Africa, told Spotlight that the Novavax trial to be conducted in South Africa will be a Phase IIb trial, which would measure efficacy, but not to the extent required for registration, for which a Phase III trial is typically needed. (Pti)

spot_img
spot_img

Related articles

RDA breaks up for polls

By Our Reporter SHILLONG, Dec 11: While the bugle for district council polls has hardly been sounded, political realignment...

Lack of interest in TMC camp; party likely to skip ADC polls

By Our Reporter SHILLONG, Dec 11: The Opposition Trinamool Congress (TMC) appears unlikely to contest the upcoming Autonomous District...

Sanbor flags concern over beef ban impact on state’s cattle trade

In a letter to Assam CM, he said Meghalaya relies heavily on road connectivity through Assam for...

Rakkam sees border hotel biz in Assam’s beef restriction

By Our Reporter SHILLONG, Dec 11: National People’s Party (NPP) leader and Education Minister Rakkam A Sangma has advised...